UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 175

Sortiert nach

Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes

Pharmaceutical research, 2001-08, Vol.18 (8), p.1091-1095

2001

Volltextzugriff (PDF)

Blood-Brain Barrier Genomics

Journal of cerebral blood flow and metabolism, 2001-01, Vol.21 (1), p.61-68

2001

Volltextzugriff (PDF)

Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor

Pharmaceutical research, 2000-03, Vol.17 (3), p.266-274

2000

Volltextzugriff (PDF)

Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization

The Journal of biological chemistry, 1990-10, Vol.265 (29), p.18035-18040

1990

Volltextzugriff (PDF)

Brain-Specific Expression of an Exogenous Gene after i.v. Administration

Proceedings of the National Academy of Sciences - PNAS, 2001-10, Vol.98 (22), p.12754-12759

2001

Volltextzugriff (PDF)

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism

Human gene therapy, 2003, Vol.14 (1), p.1-12

2003

Volltextzugriff (PDF)

Selective Expression of the Large Neutral Amino Acid Transporter at the Blood-Brain Barrier

Proceedings of the National Academy of Sciences - PNAS, 1999-10, Vol.96 (21), p.12079-12084

1999

Volltextzugriff (PDF)

Vector-Mediated Delivery of a Polyamide ("Peptide") Nucleic Acid Analogue through the Blood-Brain Barrier in vivo

Proceedings of the National Academy of Sciences - PNAS, 1995-06, Vol.92 (12), p.5592-5596

1995

Volltextzugriff (PDF)

Up‐Regulation of Blood‐Brain Barrier Short‐Form Leptin Receptor Gene Products in Rats Fed a High Fat Diet

Journal of neurochemistry, 1998-10, Vol.71 (4), p.1761-1764

1998

Volltextzugriff (PDF)

Drug Delivery of Antisense Molecules to the Brain for Treatment of Alzheimer’s Disease and Cerebral AIDS

Journal of pharmaceutical sciences, 1998-11, Vol.87 (11), p.1308-1315

1998

Volltextzugriff (PDF)

Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter

Human gene therapy, 2004-04, Vol.15 (4), p.339-350

2004

Volltextzugriff (PDF)

Brain-derived peptides increase blood–brain barrier GLUT1 glucose transporter gene expression via mRNA stabilization

Neuroscience letters, 1998-10, Vol.255 (3), p.147-150

Boado, Ruben J.

1998

Volltextzugriff (PDF)

Receptor-mediated delivery of an antisense gene to human brain cancer cells

The journal of gene medicine, 2002-03, Vol.4 (2), p.183-194

2002

Volltextzugriff (PDF)

Antisense Imaging of Gene Expression in the Brain In vivo

Proceedings of the National Academy of Sciences - PNAS, 2000-12, Vol.97 (26), p.14709-14714

2000

Volltextzugriff (PDF)

Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene

Neuroscience letters, 1996-12, Vol.220 (1), p.53-56

Boado, Ruben J.

1996

Volltextzugriff (PDF)

Glucose deprivation and hypoxia increase the expression of the GLUT1 glucose transporter via a specific mRNA cis‐acting regulatory element

Journal of neurochemistry, 2002-02, Vol.80 (3), p.552-554

2002

Volltextzugriff (PDF)

The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier

Biochemical and biophysical research communications, 1990-01, Vol.166 (1), p.174-179

1990

Volltextzugriff (PDF)

Selective Lutheran Glycoprotein Gene Expression at the Blood-Brain Barrier in Normal Brain and in Human Brain Tumors

Journal of cerebral blood flow and metabolism, 2000-07, Vol.20 (7), p.1096-1102

2000

Volltextzugriff (PDF)

Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate

Drug metabolism and disposition, 1995-01, Vol.23 (1), p.55

1995

Volltextzugriff (PDF)

Marked enhancement in gene expression by targeting the human insulin receptor

The journal of gene medicine, 2003-02, Vol.5 (2), p.157-163

2003

Volltextzugriff (PDF)

Differential Expression of Arachidonate 5-Lipoxygenase Transcripts in Human Brain Tumors: Evidence for the Expression of a Multitranscript Family

Proceedings of the National Academy of Sciences - PNAS, 1992-10, Vol.89 (19), p.9044-9048

1992

Volltextzugriff (PDF)

Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5′-untranslated region

Molecular and cellular neuroscience, 1990, Vol.1 (3), p.224-232

1990

Volltextzugriff (PDF)

Evidence for Translational Control Elements Within the 5′‐Untranslated Region of GLUT1 Glucose Transporter mRNA

Journal of neurochemistry, 1996-10, Vol.67 (4), p.1335-1343

1996

Volltextzugriff (PDF)

Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein

FEBS letters, 1991-08, Vol.288 (1-2), p.30-32

1991

Volltextzugriff (PDF)

Subtractive Expression Cloning Reveals High Expression of CD46 at the Blood-Brain Barrier

Journal of neuropathology and experimental neurology, 2002-07, Vol.61 (7), p.597-604

2002

Volltextzugriff (PDF)

1 – 25 von 175

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(167)
Mit Volltextzugriff
(126)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(111)
Animals
(106)
Life Sciences & Biomedicine
(105)
Biological And Medical Sciences
(80)
Rats
(60)
Humans
(49)
Blood-Brain Barrier
(44)
Fundamental And Applied Biological Sciences. Psychology
(41)
Male
(41)
Medical Sciences
(41)
Neurosciences & Neurology
(33)
Neurosciences
(32)
Monosaccharide Transport Proteins - Genetics
(30)
Gene Expression
(26)
Glucose Transporter Type 1
(26)
Cattle
(24)
Molecular Sequence Data
(24)
Brain - Metabolism
(21)
Endocrinology & Metabolism
(21)
Base Sequence
(20)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Receptor-mediated gene targeting to tissues in vivo following intravenous administration of pegylated immunoliposomes

Blood-Brain Barrier Genomics

Transport across the primate blood-brain barrier of a genetically engineered chimeric monoclonal antibody to the human insulin receptor

Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. Studies with quantitative western blotting and in situ hybridization

Brain-Specific Expression of an Exogenous Gene after i.v. Administration

Intravenous nonviral gene therapy causes normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism

Selective Expression of the Large Neutral Amino Acid Transporter at the Blood-Brain Barrier

Vector-Mediated Delivery of a Polyamide ("Peptide") Nucleic Acid Analogue through the Blood-Brain Barrier in vivo

Up‐Regulation of Blood‐Brain Barrier Short‐Form Leptin Receptor Gene Products in Rats Fed a High Fat Diet

Drug Delivery of Antisense Molecules to the Brain for Treatment of Alzheimer’s Disease and Cerebral AIDS

Normalization of striatal tyrosine hydroxylase and reversal of motor impairment in experimental parkinsonism with intravenous nonviral gene therapy and a brain-specific promoter

Brain-derived peptides increase blood–brain barrier GLUT1 glucose transporter gene expression via mRNA stabilization

Receptor-mediated delivery of an antisense gene to human brain cancer cells

Antisense Imaging of Gene Expression in the Brain In vivo

Brain-derived peptides increase the expression of a blood-brain barrier GLUT1 glucose transporter reporter gene

Glucose deprivation and hypoxia increase the expression of the GLUT1 glucose transporter via a specific mRNA cis‐acting regulatory element

The brain-type glucose transporter mRNA is specifically expressed at the blood-brain barrier

Selective Lutheran Glycoprotein Gene Expression at the Blood-Brain Barrier in Normal Brain and in Human Brain Tumors

Pharmacokinetics and organ clearance of a 3'-biotinylated, internally [32P]-labeled phosphodiester oligodeoxynucleotide coupled to a neutral avidin/monoclonal antibody conjugate

Marked enhancement in gene expression by targeting the human insulin receptor

Differential Expression of Arachidonate 5-Lipoxygenase Transcripts in Human Brain Tumors: Evidence for the Expression of a Multitranscript Family

Molecular cloning of the bovine blood-brain barrier glucose transporter cDNA and demonstration of phylogenetic conservation of the 5′-untranslated region

Evidence for Translational Control Elements Within the 5′‐Untranslated Region of GLUT1 Glucose Transporter mRNA

Enhanced cellular uptake of biotinylated antisense oligonucleotide or peptide mediated by avidin, a cationic protein

Subtractive Expression Cloning Reveals High Expression of CD46 at the Blood-Brain Barrier

Suchergebnisse filtern